Fierce Biotech updates the progress of late stage vaccines that if approved will begin addressing diseases with no current therapies. These vaccines if approved can help eliminate another cohort of diseases and may be blockbusters of the future. The list of vaccine-preventable diseases stands at 26, representing a major advancement in the quality of human health. Thus, one reason the Gates Foundation would like to extend this list.
There are many more vaccines in drugmakers' pipelines that are on course to eradicate some of today's most difficult-to-treat illnesses. In Kalorama Information's report on the future of emerging vaccines, the group estimates that by 2020, emerging vaccines could account for $24.7 billion in new sales up from about $16 B today.
See the emerging vaccines pipeline
Postede by Bruce Lehr November 18th 2010.
Comments